Product NDC: | 65649-431 |
Proprietary Name: | METOZOLV |
Non Proprietary Name: | METOCLOPRAMIDE HYDROCHLORIDE |
Active Ingredient(s): | 5 mg/1 & nbsp; METOCLOPRAMIDE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65649-431 |
Labeler Name: | Salix Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022246 |
Marketing Category: | NDA |
Start Marketing Date: | 20090904 |
Package NDC: | 65649-431-02 |
Package Description: | 10 BLISTER PACK in 1 CARTON (65649-431-02) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
NDC Code | 65649-431-02 |
Proprietary Name | METOZOLV |
Package Description | 10 BLISTER PACK in 1 CARTON (65649-431-02) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Product NDC | 65649-431 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | METOCLOPRAMIDE HYDROCHLORIDE |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20090904 |
Marketing Category Name | NDA |
Labeler Name | Salix Pharmaceuticals, Inc. |
Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] |